Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2006

01-09-2006 | Original Article

The Relationship of Heart Rate Variability with Severity and Prognosis of Cirrhosis

Authors: Fehmi Ates, Ergun Topal, Feridun Kosar, Melih Karincaoglu, Bulent Yildirim, Yuksel Aksoy, Murat Aladag, Murat M. M. Harputluoglu, Ulvi Demirel, Hakan Alan, Fatih Hilmioglu

Published in: Digestive Diseases and Sciences | Issue 9/2006

Login to get access

Abstract

Many studies have demonstrated that cirrhosis is frequently associated with autonomic dysfunction. The aim of this study was to test autonomic dysfunction in cirrhotic patients by analyzing heart rate variability (HRV), to determine whether or not the degree of autonomic dysfunction is correlated with the severity of disease, and, also, to compare the changes of HRV between survivor and nonsurvivor groups after 2-year follow-up periods. HRV was analyzed using 24-hr ECG recording in 30 cirrhotic patients and 28 normal controls. The changes in HRV parameters including mean normal-to-normal (N-N) interbeat intervals (mean NN), standard deviation of all N-N intervals (SDNN), standard deviation of the average of N-N intervals for each 5-min period over 24 hr (SDANN), root mean square succesive differences (r-MSSD; msec), and percentage of adjacent N-N intervals that are >50 msec apart (pNN50), all as time domain parameters, were evaluated. The cirrhotic patients were also evaluated according to Child-Pugh classification scores as markers of the disease severity. The time-domain measures of HRV in cirrhotic patients were significantly reduced compared with those in the control group (for all parameters; P < 0.001). The severity of disease was associated with reduced HRV measures (for all parameters; P < 0.001). After the 2-year follow-up periods, HRV measurements in cirrhotic patients were significantly much lower in nonsurvivors than in survivors (P < 0.001 for all). We conclude that increasing severity of cirrhosis is associated with a reduction in HRV. This finding may be an indicator of poor prognosis and mortality for cirrhosis.
Literature
1.
go back to reference Coelho L, Saraiva S, Guimaraes H, Freitas D, Providencia LA (2001) Autonomic function in chronic liver disease assessed by heart rate variability study. Rev Port Cardiol 20(1):25–36PubMed Coelho L, Saraiva S, Guimaraes H, Freitas D, Providencia LA (2001) Autonomic function in chronic liver disease assessed by heart rate variability study. Rev Port Cardiol 20(1):25–36PubMed
2.
go back to reference Fleisher LA, Fleckenstein JF, Frank SM, Thuluvath PJ (2000) Heart rate variability as a predictor of autonomic dysfunction in patients awaiting liver transplantation. Dig Dis Sci 45(2):340–344PubMedCrossRef Fleisher LA, Fleckenstein JF, Frank SM, Thuluvath PJ (2000) Heart rate variability as a predictor of autonomic dysfunction in patients awaiting liver transplantation. Dig Dis Sci 45(2):340–344PubMedCrossRef
3.
go back to reference Trevisani F, Sica G, Mainqua P, Santese G (1999) Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites. Hepatology 30(6):1387–1392PubMedCrossRef Trevisani F, Sica G, Mainqua P, Santese G (1999) Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites. Hepatology 30(6):1387–1392PubMedCrossRef
4.
go back to reference Task Force of the European Society of Cardiology and North American Society of Pacing and Electrophysiology (1996) Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation 93(5):1043–1065 Task Force of the European Society of Cardiology and North American Society of Pacing and Electrophysiology (1996) Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation 93(5):1043–1065
5.
go back to reference Thuluvath PJ, Triger DR (1989) Autonomic neuropathy and chronic liver disease. Q J Med 72(268):737–747PubMed Thuluvath PJ, Triger DR (1989) Autonomic neuropathy and chronic liver disease. Q J Med 72(268):737–747PubMed
6.
go back to reference Lunzer MR, Newman SP, Bernard AG, et al. (1975) Impaired cardiovascular responsiveness in liver disease. Lancet 2(7931):382–385PubMedCrossRef Lunzer MR, Newman SP, Bernard AG, et al. (1975) Impaired cardiovascular responsiveness in liver disease. Lancet 2(7931):382–385PubMedCrossRef
7.
go back to reference Giancane S, Bernardi M, Trevisani F, et al. (1991) Autonomic neuropathy in liver cirrhosis: prevalence and association with clinical and laboratory features. In: Costa M, Surrenti C, Gorini S, Maggi CA, Meli A (eds) Sensory nerves and neuropeptides in gastroenterology. from basic science to clinical perspectives. Plenum Press, New York, pp 295–300 Giancane S, Bernardi M, Trevisani F, et al. (1991) Autonomic neuropathy in liver cirrhosis: prevalence and association with clinical and laboratory features. In: Costa M, Surrenti C, Gorini S, Maggi CA, Meli A (eds) Sensory nerves and neuropeptides in gastroenterology. from basic science to clinical perspectives. Plenum Press, New York, pp 295–300
8.
go back to reference Hendrickse MT, Triger DR (1992) Peripheral and cardiovascular autonomic impairment in chronic liver disease: Prevalence and relation to hepatic function. J Hepatol 16:177–183PubMedCrossRef Hendrickse MT, Triger DR (1992) Peripheral and cardiovascular autonomic impairment in chronic liver disease: Prevalence and relation to hepatic function. J Hepatol 16:177–183PubMedCrossRef
9.
go back to reference Dillon JF, Plevris JN, Nolan J, Ewing DJ, Neilson JM, Bouchier IA, Hayes PC (1994) Autonomic function in cirrhosis assessed by cardiovascular reflex tests and 24-hour heart rate variability. Am J Gastroenterol 89:1544–1547PubMed Dillon JF, Plevris JN, Nolan J, Ewing DJ, Neilson JM, Bouchier IA, Hayes PC (1994) Autonomic function in cirrhosis assessed by cardiovascular reflex tests and 24-hour heart rate variability. Am J Gastroenterol 89:1544–1547PubMed
10.
go back to reference Laffi G, Lagi A, Cipriani M, et al. (1996) Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. Hepatology 24:1063–1067PubMedCrossRef Laffi G, Lagi A, Cipriani M, et al. (1996) Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. Hepatology 24:1063–1067PubMedCrossRef
11.
go back to reference Chaudhry V, Corse AM, O’Brien R, Cornblath DR, Klein AS, Thuluvath PJ (1999) Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study. Hepatology 29:1689–1703CrossRef Chaudhry V, Corse AM, O’Brien R, Cornblath DR, Klein AS, Thuluvath PJ (1999) Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study. Hepatology 29:1689–1703CrossRef
12.
go back to reference Hendrickse MT, Thuluvath PJ, Triger DR (1992) Natural history of autonomic neuropathy in chronic liver disease. Lancet 339:1462–1464PubMedCrossRef Hendrickse MT, Thuluvath PJ, Triger DR (1992) Natural history of autonomic neuropathy in chronic liver disease. Lancet 339:1462–1464PubMedCrossRef
13.
go back to reference Hendrickse MT, Triger DR (1993) Autonomic dysfunction in chronic liver disease. Clin Auton Res 3:227–231PubMedCrossRef Hendrickse MT, Triger DR (1993) Autonomic dysfunction in chronic liver disease. Clin Auton Res 3:227–231PubMedCrossRef
14.
go back to reference Fleckenstein JF, Frank SM, Thuluvath PJ (1996) Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease. Hepatology 23:471–475PubMedCrossRef Fleckenstein JF, Frank SM, Thuluvath PJ (1996) Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease. Hepatology 23:471–475PubMedCrossRef
15.
go back to reference Decaux G, Cauchie P, Soupart A, Kruger M, Delwiche F (1986) Role of vagal neuropathy in the hyponatraemia of alcoholic cirrhosis. Br Med J 293:1534–1536CrossRef Decaux G, Cauchie P, Soupart A, Kruger M, Delwiche F (1986) Role of vagal neuropathy in the hyponatraemia of alcoholic cirrhosis. Br Med J 293:1534–1536CrossRef
16.
go back to reference Mohamed R, Forsey PR, Davies MK, Neuberger JM (1996) Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology 23:1128–1134PubMedCrossRef Mohamed R, Forsey PR, Davies MK, Neuberger JM (1996) Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology 23:1128–1134PubMedCrossRef
17.
go back to reference Bernardi M, Calandra S, Colantoni A, et al. (1998) Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 27:28–34PubMedCrossRef Bernardi M, Calandra S, Colantoni A, et al. (1998) Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 27:28–34PubMedCrossRef
18.
go back to reference Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649PubMedCrossRef Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649PubMedCrossRef
19.
go back to reference Ewing DJ, Clarke BF (1986) Autonomic neuropathy: its diagnosis and prognosis. Clin Endocrinol Metab 15:855–888PubMedCrossRef Ewing DJ, Clarke BF (1986) Autonomic neuropathy: its diagnosis and prognosis. Clin Endocrinol Metab 15:855–888PubMedCrossRef
20.
go back to reference O’Brien IA, O’Hare P, Corrall RJ (1986) Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function. Br Heart J 55:348–354PubMedCrossRef O’Brien IA, O’Hare P, Corrall RJ (1986) Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function. Br Heart J 55:348–354PubMedCrossRef
21.
go back to reference Dillon JF, Nolan J, Thomas H, Williams BC, Neilson JMM, Bouchier IAD, Hayes PC (1997) The correction of autonomic dysfunction in cirrhosis by captopril. J Hepatol 26:331–335PubMedCrossRef Dillon JF, Nolan J, Thomas H, Williams BC, Neilson JMM, Bouchier IAD, Hayes PC (1997) The correction of autonomic dysfunction in cirrhosis by captopril. J Hepatol 26:331–335PubMedCrossRef
22.
go back to reference Bernardi M, Trevisani F, Santini C, Zoli G, Baraldini M, Ligabue A, Gasbarrini G (1983) Plasma norepinephrine, weak neurotransmitters and renin activity during active tilting in liver cirrhosis. Relationship with cardiovascular homeostasis and renal function. Hepatology 3:56–64PubMedCrossRef Bernardi M, Trevisani F, Santini C, Zoli G, Baraldini M, Ligabue A, Gasbarrini G (1983) Plasma norepinephrine, weak neurotransmitters and renin activity during active tilting in liver cirrhosis. Relationship with cardiovascular homeostasis and renal function. Hepatology 3:56–64PubMedCrossRef
23.
go back to reference Gerbes AL, Remien J, Jungst D, Sauerbruch T, Paumgartner G (1986) Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet 1:1409–1411PubMedCrossRef Gerbes AL, Remien J, Jungst D, Sauerbruch T, Paumgartner G (1986) Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet 1:1409–1411PubMedCrossRef
24.
go back to reference Campillo B, Chabrier PE, Pelle G, Sediane S, Atlan G, Fouet P, Adnot S (1995) Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 22:1423–1429PubMed Campillo B, Chabrier PE, Pelle G, Sediane S, Atlan G, Fouet P, Adnot S (1995) Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 22:1423–1429PubMed
Metadata
Title
The Relationship of Heart Rate Variability with Severity and Prognosis of Cirrhosis
Authors
Fehmi Ates
Ergun Topal
Feridun Kosar
Melih Karincaoglu
Bulent Yildirim
Yuksel Aksoy
Murat Aladag
Murat M. M. Harputluoglu
Ulvi Demirel
Hakan Alan
Fatih Hilmioglu
Publication date
01-09-2006
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9073-9

Other articles of this Issue 9/2006

Digestive Diseases and Sciences 9/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine